Antianxiety Drugs

Definition
Purpose
Description
Recommended dosage
Precautions
Interactions
Side effects

Definition

Antianxiety drugs are medicines that calm and relax people with excessive anxiety, nervousness, or tension, or for short-term control of social phobia disorder or specific phobia disorder.

Purpose

Antianxiety agents, or anxiolytics, may be used to treat mild transient bouts of anxiety as well as more pronounced episodes of social phobia and specific phobia. Clinically significant anxiety is marked by several symptoms. The patient experiences marked or persistent fear of one or more social or performance situations in which he or she is exposed to unfamiliar people or possible scrutiny by others, and may react in a humiliating or embarrassing way. The exposure to the feared situation produces an anxiety attack. Fear of these episodes of anxiety leads to avoidance behavior, which impairs normal social functioning, including working or attending classes. The patient is aware that these fears are unjustified.

Antianxiety drugs, particularly the injectable benzodiazepines lorazepam (Ativan) and midazolam (Versed) are also used for preoperative sedation in surgery. Used for this purpose, they may induce relaxation, provide sedation, and also reduce memory of an unpleasant experience. They offer the combined benefits of relaxing the patient and reducing the need for other agents including analgesics, anesthetics, and muscle relaxants. Lorazepam is also used to treat the nausea and vomiting from cancer treatments, epilepsy, irritable bowel syndrome, and insomnia.

Description

In psychiatric practice, treatment of anxiety has largely turned from traditional antianxiety agents, anxiolytics, to antidepressant therapies. The benzodiazepines, the best-known class of anxiolytics, have been largely supplanted by serotonin-specific reuptake nhibitors (SSRIs, including citalopram, fluoxetine, fluvoxamine, and others), which have a milder side effect profile and less risk of dependency. Traditional anxiolytics remain useful for patients who need a rapid SSRIs may require three to five weeks to show any effects, and must be taken continuously, benzodiazepines may produce a response within 30 minutes, and may be dosed on an as-needed basis

The intermediate-action benzodiazepines, alpra-zolam (Xanax), and lorazepam (Ativan), are the appropriate choice for treatment of mild anxiety and social phobia. Diazepam (Valium) is still widely used for anxiety, but its active metabolite, desmethyldiazepam, has a long half-life, making this a poorer choice than other drugs in its class. There is considerable variation between individuals in the metabolism of benzodiazepines, so patient response may not be predictable. As a class, benzodiazepines are used not only as anxiolytics, but also as sedatives, muscle relaxants (making them useful in the treatment of fibromyalgia and restless leg syndrome), and in treatment of epilepsy and alcoholism. The distinctions between these uses are largely determined by onset and duration of action, and route of administration.

Buspirone (BuSpar), which is not chemically related to other classes of central nervous system drugs, is also a traditional anxiolytic, although it is considered either a third-line or adjunctive agent for use after trials of SSRIs and benzodiazepines. It is appropriate for use in patients who have either failed trials of other treatments, or who should not receive benzodiazepines because of a history of substance abuse problems. Buspirone, in common with antidepressants, requires a two- to three-week

KEY TERMS

Anxiety— Worry or tension in response to real or imagined stress, danger, or dreaded situations. Physical reactions such as fast pulse, sweating, trembling, fatigue, and weakness may accompany anxiety.

Epilepsy— A brain disorder with symptoms that include seizures.

Panic disorder— An disorder in which people have sudden and intense attacks of anxiety in certain situations.

Phobia— An intense, abnormal, or illogical fear of something specific such as heights or open spaces.

Pregnancy category B— Animal studies indicate no fetal risk, but no human studies; or adverse effects in animals, but not in well-controlled human studies.

Pregnancy category C— No adequate human or animal studies; or adverse fetal effects in animal studies, but no available human data.

Seizure— A sudden attack, spasm, or convulsion.

period before there is clinical evidence of improvement, and must be continuously dosed to maintain its effects. Buspirone causes drowsiness, so patients should be careful not to drive or operate machinery until they know how the drug affects them.

In surgery, antianxiety drugs may be used to provide relaxation and reduce fear of surgery. They may reduce the need for anesthetics and muscle relaxants. In addition, some antianxiety drugs may impair memory, which is a benefit since it reduces concern about an unpleasant experience. Short-acting benzodiazepines such as midazolam (Versed) and lorazepam (Ativan) are most often used for this purpose.

Benzodiazepines are controlled drugs under federal law. Buspirone is not a controlled substance and has no established abuse potential.

Recommended dosage

Presurgical dosing of midazolam varies with the route of administration, the age and physical condition of the patient, and the other drugs to be used. For patients under the age of 60 who have not received narcotic analgesics, a dose of 2-3 milligrams (mg) is normally adequate, but some elderly patients may respond to a dose as low as 1 mg. The usual dose of lorazepam is up to 4 mg, administered by intramuscular injection at least two hours prior to surgery. If the drug is given intravenously, a dose of up to 2 mg may be given 15-20 minutes before surgery.

Benzodiazepines should be administered 30–60 minutes before exposure to the anticipated stress. Dosage should be individualized to minimize sedation. The normal dose of alprazolam is 0.25–0.5 mg. The usual dose of lorazepam is 2–3 mg. Doses may be repeated if necessary.

Buspirone is initially dosed at 5 mg three times a day, as a tablet taken by mouth. The dosage should be increased 5 mg/day, at intervals of two to three days, as needed. A dosage of 60 mg/day should not be exceeded. Two to three weeks may be required before a satisfactory response is observed.

Precautions

Precautions and warnings apply to the use of antianxiety agents for use over long periods of time. They are unlikely to occur in patients who have only received a single dose prior to surgery.

Benzodiazepines should not be used in patients with psychosis, acute narrow-angle glaucoma, or liver disease. The drugs can act as respiratory depressants and should be avoided in patients with respiratory conditions. Benzodiazepines are potentially addictive and should not be administered to patients with substance abuse disorders. Benzodiazepines are sedatives and should be avoided in patients who must remain alert. Their use for periods over four months has not been documented. These drugs should not be used during the second and third trimester of pregnancy, although use during the first trimester appears to be safe. They should not be taken while breastfeeding. Specialized references for use in children should be consulted.

Buspirone is metabolized by the liver and excreted by the kidney, and should be used with care in patients with hepatic or renal disease. The drug is classified as schedule B during pregnancy, but should not be taken during breast-feeding. Its use in children under the age of 18 years has not been studied.

Interactions

The metabolism of alprazolam may be increased by cimetidine, oral contraceptives, disulfiram, fluoxetine, isoniazid, ketoconazole, metoprolol, propoxyphene, propranolol, and valproic acid. The absorption of all benzodiazepines is inhibited by concomitant use of antacids. Benzodiazepines may increase blood levels of digoxin, and reduce the efficacy of levodopa. Other drug interactions have been reported.

Buspirone levels will be increased by concomitant use of erythromycin, itraconazole, and nefazadone. Doses should be adjusted based on clinical response. Use of buspirone at the same time as monoamine oxidase inhibitors (MAOIs, including phenelzine and tranycypromine) may cause severe blood pressure elevations. Use of buspirone with MAOIs should be avoided.

Side effects

The most common side effects of benzodiazepines are secondary to their central nervous system (CNS) effects and include sedation and sleepiness, depression, lethargy, apathy, fatigue, hypoactivity, lightheadedness, memory impairment, disorientation, anterograde amnesia, restlessness, confusion, crying or sobbing, delirium, headache, slurred speech, aphonia, dysarthria, stupor, seizures, coma, syncope, rigidity, tremor, dystonia, vertigo, dizziness, euphoria, nervousness, irritability, difficulty in concentration, agitation, inability to perform complex mental functions, akathisia, hemiparesis, hypotonia, unsteadiness, ataxia, incoordination, weakness, vivid dreams, psychomotor retardation, “glassy-eyed” appearance, extrapyramidal symptoms, and paradoxical reactions. Other reactions include changes in heart rate and blood pressure, changes in bowel function, severe skin rash, and changes in genitourinary function. Other adverse effects have been reported.

Buspirone has a low incidence of side effects. Dizziness and drowsiness are the most commonly reported adverse effects. The drug may also cause difficulty sleeping, nervousness, lightheadedness, weakness, excitement, fatigue, depression, headache, fast or irregular heartbeat, blurred vision, and unusual movements of the head or neck muscles. Other CNS effects include dream disturbances, depersonalization, dysphoria, noise intolerance, euphoria, akathisia, fearfulness, loss of interest, disassociative reaction, hallucinations, suicidal ideation, seizures, feelings of claustrophobia, cold intolerance, stupor and slurred speech, and psychosis. Rarely, heart problems, including congestive heart failure and myocardial infarction, have been reported. Other adverse effects have been reported.

Resources

BOOKS

AHFS: Drug Information 2007. Washington, DC: American Society of Health-System Pharmacists, 2007.

Brody, T. M., J. Larner, and K. P. Minneman. Human Pharmacology: Molecular to Clinical, 3rd ed. St. Louis: Mosby, 1998.

Karch, A. M. 2008 Lippincott’s Nursing Drug Guide. Philadelphia, PA: Lippincott Williams & Wilkins, 2007.

Racagni, G., C. Massotto, and L. Steardo. Pharmacology of Anxiolytic Drugs, WHO Expert Series on Neuroscience, vol. 3. Cambridge, MA: Hogrefe and Huber, 1997.

Sweetman, Sean C., ed. Martindale: The Complete Drug Reference, 35th ed. London: The Pharmaceutical Press, 2007.

OTHER

“Busiprone.” Medline Plus. April 1, 2003. http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a688005.html (February 2008).

“Fibromyalgia.” National Institute of Arthritis and Musculoskeletal and Skin Diseases. December 1999. http://www.niams.nih.gov/Health_Info/Fibromyalgia/default.asp (February 2008).

“Lorazepam.” Medline Plus. April 1, 2003. http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a68205.html (February 2008).

Sam Uretsky, Pharm.D.

Fran Hodgkins

Antibiotic prophylaxis seeProphylaxis, antibiotic